BioGend Therapeutics Co., Ltd. (TPEX:6733)

BioGend Therapeutics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	3,526	4,775	4,181	4,708	2,247	2,757
Market Cap Growth	-38.31%	14.21%	-11.18%	109.50%	-18.50%	-22.86%
Enterprise Value	2,693	4,269	3,558	3,990	1,720	2,063
Last Close Price	26.25	38.28	33.55	38.13	21.73	26.32

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PS Ratio	14.90	21.48	24.94	42.83	71.46	297.47
PB Ratio	3.27	6.30	4.94	4.92	3.07	2.92
P/TBV Ratio	3.54	7.33	6.09	6.09	4.73	4.53

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	11.38	19.20	21.22	36.30	54.70	222.54

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.00	0.01	0.01	0.01	0.02	0.01
Net Debt / Equity Ratio	-0.78	-0.67	-0.72	-0.74	-0.65	-0.73
Net Debt / EBITDA Ratio	18.28	7.94	8.15	5.68	2.80	4.97
Net Debt / FCF Ratio	16.85	7.80	6.12	4.32	2.56	4.98
Asset Turnover	0.24	0.26	0.17	0.12	0.03	0.01
Inventory Turnover	3.16	3.41	2.29	1.89	1.24	0.64
Quick Ratio	31.12	16.84	21.06	16.90	16.73	28.58
Current Ratio	32.13	17.60	21.60	17.32	17.01	29.24
Return on Equity (ROE)	-8.17%	-11.88%	-13.30%	-19.07%	-24.54%	-17.51%
Return on Assets (ROA)	-5.83%	-7.99%	-7.78%	-11.79%	-14.85%	-11.74%
Return on Capital Employed (ROCE)	-8.40%	-14.20%	-13.90%	-17.60%	-27.70%	-16.50%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	-1.92%	-1.77%	-2.79%	-3.32%	-8.21%	-5.02%
FCF Yield	-1.42%	-1.37%	-2.38%	-3.50%	-8.32%	-4.99%
Buyback Yield / Dilution	-1.75%	-	-2.32%	-16.69%	-1.77%	-15.90%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 8, 2026

Data Sources Report a data error